• A phase 1 trial of 90Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myeloma
    This phase 1 study (clinical trial NCT00477815) was conducted to determine the maximum tolerated dose (MTD) of yttrium-90 ibritumomab tiuxetan (90Y-Zevalin) with high dose melphalan (HDM) therapy in multiple myeloma (MM) patients undergoing autologous stem cell transplantation (ASCT).

  • In vitro and in vivo imaging and tracking of intestinal organoids from human-induced pluripotent stem cells
    Human intestinal organoids (hIOs) derived from human pluripotent stem cells (hPSCs) have immense potential as a source of intestines.

  • Global CAR T Cell Therapy Market to Reach US$ 8.5 Billion by 2028
    The Global Car T Cell Therapy Market is expected to be valued at US$ 8.5 Billion by 2028, as analyzed by Coherent Market Insights. Increasing demand for genetically engineered treatment approach for high success rate in cancer treatment along with growing cancer incidence rate are key factors driving demand for CAR T cell therapy products worldwide.

  • Engineered T cells for all
    Gene-engineered autologous T cells with chimeric antigen receptors (CARs) against CD19 (CART19 cells) have been effective against patients with CD19+ B cell malignancies.

  • UCLA Launches First-of-Its-Kind Stem Cell Trial to Combat Cancer
    Scientists at UCLA have launched the first genetically engineered blood stem cell clinical trial to fight cancer thanks to $20 million in voter-approved funds earmarked for stem cell research, university officials announced Monday.

 

 

 

 

 

Vice-presidency News
President Rouhani Appointed Dr Sorena Sattari as Vice-President for Science and Technology
According to Article 124 of the Constitution of the Islamic Republic of Iran and based on your commitment and experience, you are being appointed as "Vice-President for Science and Technology".
 11:57 - 17/08/2017 - Comments : 0More >>
Vatani Expressed:
Significant Participation of Students in Festival of Stem Cells Promises a Bright Future for this Field of Science.
Ali Vatani, deputy of technology development of the Vice-Presidency for science and technology affairs, visited the booths of knowledge-based companies and student section of the festival. He stated about the festival: various councils are active in the Vice-Presidency for science and technology affairs, including council for stem cells science and technologies, which has received the highest attention and investment since its establishment.
 10:27 - 23/07/2017 - Comments : 0More >>
World News
A phase 1 trial of 90Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myeloma
This phase 1 study (clinical trial NCT00477815) was conducted to determine the maximum tolerated dose (MTD) of yttrium-90 ibritumomab tiuxetan (90Y-Zevalin) with high dose melphalan (HDM) therapy in multiple myeloma (MM) patients undergoing autologous stem cell transplantation (ASCT).
 13:07 - 20/09/2017 - Comments : 0More >>
In vitro and in vivo imaging and tracking of intestinal organoids from human-induced pluripotent stem cells
Human intestinal organoids (hIOs) derived from human pluripotent stem cells (hPSCs) have immense potential as a source of intestines.
 08:24 - 20/09/2017 - Comments : 0More >>
Council News
The Most Important Event in the Field of Stem Cells and Regenerative Medicine Is Ended.
Amir Ali Hamidieh, secretary of council for stem cells science and technologies, expressed the warm welcome of the festival at the closing ceremony of the event, stating: given the warm welcome by the participants, registration for the event ended two weeks before festival beginning due to the great number of referrals. In total, three thousand individuals participated in the second round of this festival.
 10:31 - 23/07/2017 - Comments : 0More >>
Along with Holding the Second National Festival and International Congress of Stem Cells and Regenerative Medicine;
Non-resident Iranian Experts Visited Pardis Technology Park of Science and Technology at the Vice-Presidency for Science and Technology Affairs.
According to the public relations and information center of the Vice-Presidency for science and technology affairs, in line with initiation of cooperation between non-resident Iranian experts and science and technology centers of the country and defining the method of this cooperation and knowledge-based businesses, council for stem cells science and technologies held a brainstorming meeting in the presence of non-resident scientists and researchers at Pardis technology park. After the meeting, the technological achievements in the field of stem cells were visited by non-resident Iranian experts.
 09:22 - 23/07/2017 - Comments : 0More >>
National News
Secretary General of the Second National Festival and International Congress on Stem Cell and Regenerative Medicine:
The Festival of Stem Cell and Regenerative Medicine Is the Biggest Meeting of Activist in this Field of Science
In the field of modern sciences, Iran has an reasonable development which in the field of stem cells, nanotechnology and nuclear energy these developments are more significant and good future for these technologies are imaginable in Iran.
 11:26 - 17/04/2017 - Comments : 0More >>
Novartis announces first CAR-T cell therapy BLA for pediatric and young adult patients with r/r B-cell ALL granted FDA Priority Review
Novartis announced today that the US Food and Drug Administration (FDA) has accepted the companys Biologics License Application (BLA) filing and granted priority review for CTL019, an investigational chimeric antigen receptor T cell (CAR-T) therapy, in relapsed and refractory (r/r) pediatric and young adult patients with B-cell acute lymphoblastic leukemia (ALL). This is the first BLA submission by Novartis for a CAR-T. The priority review designation is expected to shorten the anticipated review time by the FDA.
 16:20 - 04/04/2017 - Comments : 0More >>